Answers are grounded in this paper and cite their sources.
Aim: Melatonin has been found to inhibit the induced Tau hyperphosphorylation in cellular and animal models. However, the underlying mechanisms are not fully understood, especially with respect to the ability of melatonin to control Tau-related pathologies and neuronal damage. Methods: 6-month-old male P301S mice were employed to evaluate the effects of intranasally administered melatonin (10 mg/kg) on tauopathy progression and ferroptosis. HT22 and D1A cells were also employed to further uncover the mechanism of melatonin on Tau hyperphosphorylation and neuronal iron metabolism. Results: We verified that intranasal melatonin administration effectively improved Tau hyperphosphorylation via modulating the activity of several kinases, accompanied by a stifling of synaptic loss, neuronal degeneration, neuroinflammation, and oxidative damage in P301S Tau transgenic mice. Moreover, restoration of ferroptosis-related indicators such as iron accumulation in hippocampal neurons, iron metabolism, and activating Nrf2/GPX4 signaling also contributed to the underlying mechanisms by which melatonin supplementation ameliorated behavioral deficits of the mice. Interestingly, we found that melatonin treatment may stimulate astrocytes to secrete hepcidin in vitro, which in turn helps alleviate neuronal iron efflux and Tau hyperphosphorylation in stressed conditions. Conclusion: These findings provide compelling evidence that melatonin plays a role in improving tauopathies and ferroptosis in neurodegenerative disease.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: